Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Public ClinicalTrials.gov record NCT03138733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole Medocaril Compared to Daptomycin in the Treatment of Staphylococcus Aureus Bacteremia, Including Infective Endocarditis
Study identification
- NCT ID
- NCT03138733
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Basilea Pharmaceutica
- Industry
- Enrollment
- 390 participants
Conditions and interventions
Conditions
Interventions
- Ceftobiprole medocaril Drug
- Daptomycin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2018
- Primary completion
- Mar 10, 2022
- Completion
- Mar 10, 2022
- Last update posted
- Nov 7, 2023
2018 – 2022
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| eStudy Site - Chula Vista - PPDS | Chula Vista | California | 91911 | — |
| Triple O Medical Services Inc | West Palm Beach | Florida | 33407 | — |
| Mercury Street Medical Group | Butte | Montana | 59701 | — |
| eStudy Site - Las Vegas - PPDS | Las Vegas | Nevada | 89109 | — |
| Remington Davis Inc. | Columbus | Ohio | 43214 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03138733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03138733 live on ClinicalTrials.gov.